The fact that all the retinal tumours remained stable and no new tumours appeared during the follow-up period, without any other treatment but propranolol suggests that propranolol is a promising therapeutic drug for retinal haemangioblastomas, and perhaps for other ocular pathologies with retinal exudation and high VEGF levels (as macular degeneration). Here, VEGFA is linked to retina neoplasm.